Core Insights - The Goldman Sachs Future Health Care Equity ETF (GDOC) has reached a 52-week high and is up 31.1% from its 52-week low of $28.34 per share, attracting investor attention for potential momentum [1][3] Group 1: Fund Overview - GDOC provides exposure to both U.S. and non-U.S. health care companies, with an annual fee of 75 basis points [2] Group 2: Factors Contributing to Performance - The rise in GDOC's price can be attributed to several factors, including an aging global population, advancements in technology and medicine such as AI integration and precision medicine, and an increase in health care mergers and acquisitions [3] - Eli Lilly (LLY), a major pharmaceutical company that recently surpassed a $1 trillion market cap, is the top holding in GDOC and has likely contributed to the ETF's recent price increase [3] Group 3: Future Outlook - GDOC is expected to maintain strong performance in the near term, indicated by a positive weighted alpha of 16.34, suggesting potential for further gains [4]